PLX4032, a highly selective (V600E)BRAF kinase inhibitor: Clinical correlation of activity with pharmacokinetic and pharmacodynamic parameters in a phase I trial Meeting Abstract
| Authors: | Puzanov, I.; Nathanson, K. L.; Chapman, P. B.; Xu, X.; Sosman, J. A.; McArthur, G. A.; Ribas, A.; Kim, K. B.; Grippo, J. F.; Flaherty, K. T. |
| Abstract Title: | PLX4032, a highly selective (V600E)BRAF kinase inhibitor: Clinical correlation of activity with pharmacokinetic and pharmacodynamic parameters in a phase I trial |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 466s |
| Language: | English |
| ACCESSION: | WOS:000276606606037 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.9021 |
| Notes: | Meeting Abstract: 9021 -- Source: Wos |
